Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis.
暂无分享,去创建一个
Fiona J Gilbert | Linda Pointon | Martin O Leach | Sunil R Lakhani | R. Warren | D. Easton | S. Lakhani | F. Gilbert | D. Thompson | A. Padhani | M. Leach | L. Pointon | R. Hoff | Doug Easton | Deborah Thompson | Ruth M L Warren | Anwar Padhani | Rebecca Hoff
[1] A R Padhani,et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.
[2] Ellen Warner,et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.
[3] H. D. de Koning,et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.
[4] Matthijs Oudkerk,et al. First experiences in screening women at high risk for breast cancer with MR imaging , 2000, Breast Cancer Research and Treatment.
[5] R. Tollenaar,et al. MRI screening for breast cancer in women with high familial and genetic risk: First results of the Dutch MRI screening study (MRISC). , 2003 .
[6] M. Fuhrer. Overview of Clinical Trials in Medical Rehabilitation: Impetuses, Challenges, and Needed Future Directions , 2003, American journal of physical medicine & rehabilitation.
[7] L. Liberman,et al. Probably benign lesions at breast magnetic resonance imaging , 2003, Cancer.
[8] Kuhl Ck. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene). , 2002 .
[9] C. Zuiani,et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. , 2002, Journal of experimental & clinical cancer research : CR.
[10] R. Warren,et al. What is the recall rate of breast MRI when used for screening asymptomatic women at high risk? , 2002, Magnetic resonance imaging.
[11] C. Kuhl. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene). , 2002, Journal of experimental & clinical cancer research : CR.
[12] Ruth Warren. Is breast MRI mature enough to be recommended for general use? , 2001, The Lancet.
[13] P. Chappuis,et al. Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. , 2001, Journal of the National Cancer Institute.
[14] J O Barentsz,et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. , 2001, Journal of the National Cancer Institute.
[15] R. Warren,et al. Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study , 2000 .
[16] E A Sickles,et al. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. , 2000, AJR. American journal of roentgenology.
[17] P. Aspelin,et al. The potential influence of fine-needle aspiration on MR imaging of the breast. , 2000, Acta radiologica.
[18] D Krebs,et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. , 2000, Radiology.
[19] M O Leach,et al. Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer. , 2000, Breast.
[20] R. Warren,et al. Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer. , 2000, Breast.
[21] G Lutterbey,et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. , 1997, Radiology.
[22] K. Macrae. Pragmatic Versus Explanatory Trials , 1989, International Journal of Technology Assessment in Health Care.
[23] P. J. Huber. The behavior of maximum likelihood estimates under nonstandard conditions , 1967 .
[24] E. Brockbank,et al. THE MANCHESTER MEDICAL SCHOOL. , 1927 .
[25] G. Irvine. ROYAL HOSPITAL, HASLAR.: A CASE OF CEREBRAL HÆMORRHAGE PRESENTING SEVERAL UNUSUAL FEATURES ; NECROPSY , 1900 .
[26] A. Prichard. Bristol Royal Infirmary , 1857, British medical journal.
[27] A. Prichard. BRISTOL ROYAL INFIRMARY , 1856, Association medical journal.